MFT
HAE icon

Moisand Fitzgerald Tamayo’s Haemonetics HAE Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40
Closed -$3.58K – 722
2023
Q3 		$3.58K Hold
40
– – ﹤0.01% 477
2023
Q2 		$3.41K Hold
40
– – ﹤0.01% 455
2023
Q1 		$3.31K Hold
40
– – ﹤0.01% 468
2022
Q4 		$3.15K Hold
40
– – ﹤0.01% 471
2022
Q3 		$3K Buy
+40
New +$2.87K ﹤0.01% 436

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moisand Fitzgerald Tamayo's HAE Position: Q4 2023 in Review

Moisand Fitzgerald Tamayo sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 40 shares — an estimated $3.58K sold.

Moisand Fitzgerald Tamayo first reported a position in HAE in Q3 2022 and held it in 5 quarters. The position peaked at $3.58K in Q3 2023. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

  • Moisand Fitzgerald Tamayo reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 40 Haemonetics shares in Q4 2023, an estimated $3.58K.
  • Moisand Fitzgerald Tamayo first reported a position in Haemonetics in Q3 2022 and held it in 5 quarters.
  • Moisand Fitzgerald Tamayo's Haemonetics position peaked at $3.58K in Q3 2023.
  • 295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q4 2023, filed 18 Jan 2024.